Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2026

Conditions
HypertensionBlood PressureCardiovascular Diseases
Interventions
DEVICE

focused power ultrasound mediate inferior perirenal adipose tissue modification

"This novel focused power ultrasound is an externally delivered, completely noninvasive focused therapeutic ultrasound device. It is capable of focusing the resulting ultrasound beam to a small cigar-shaped volume and monitoring the temperature of the target area, which leads to the rapid elevation of the peri-renal adipose tissue temperature and the destruction of target tissue eventually."

DEVICE

Sham-control group

Participants will receive the sham control therapy(including peri-renal fat ultrasonic measurement and localization,focused ultrasound treatment parameters setting),however,without initiating the focused ultrasound equipment.

Trial Locations (4)

210000

RECRUITING

The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing

RECRUITING

The first Affiliated Hospital of Nanjing Medical University, Nanjing

RECRUITING

Affiliated Hospital of Nantong University, Nantong

RECRUITING

Suzhou Municipal Hospital, Suzhou

All Listed Sponsors
collaborator

The Affiliated Jiangning Hospital of Nanjing Medical University

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Affiliated Hospital of Nantong University

OTHER

lead

Suzhou Municipal Hospital

OTHER